ICD-10-CM Code for History of Abnormal Pap Smear
The ICD-10-CM code for a patient with a history of an abnormal Pap smear is Z87.410 (Personal history of cervical dysplasia).
Code Selection and Clinical Context
The appropriate code depends on what you mean by "history of abnormal Pap":
- Z87.410: Personal history of cervical dysplasia - Use this when the patient had a previously abnormal Pap that has been treated or resolved, and you're documenting this historical finding
- Z12.4: Encounter for screening for malignant neoplasm of cervix - Use this for routine screening visits
- R87.619: Unspecified abnormal cytological findings in specimens from cervix uteri - Use this for a current abnormal Pap result that is being worked up
Key Clinical Considerations
The distinction matters for screening intervals and management. Women with a history of cervical dysplasia require continued surveillance even after treatment. According to current guidelines, screening should not stop at age 65 in women with a history of abnormal results, even if recent tests are normal 1.
Common Pitfalls to Avoid
- Don't confuse historical vs. current findings: Z87.410 is for resolved abnormalities; active abnormalities require specific cytology codes (R87.6xx series)
- Don't use unspecified codes when detail is available: While ICD-10-CM offers extensive specificity, studies show 33.3% of codes used are unspecified variants 2. Be as specific as possible about the type of dysplasia if known (CIN 1, CIN 2, CIN 3)
- Remember that HPV vaccination status doesn't change coding: Women vaccinated against HPV need the same screening and coding as unvaccinated women 1
Documentation Requirements
For proper code assignment, your documentation should specify:
- Whether the abnormality is current or historical
- The specific cytologic finding if known (ASC-US, LSIL, HSIL, etc.)
- Treatment received (if applicable)
- Current surveillance plan
The Z87.410 code signals to other providers and insurers that this patient requires continued monitoring beyond standard screening protocols, which is clinically important for ensuring appropriate follow-up care 1, 3.